Company news and developments, with original sources and dates.
Updated from source·Oct 18, 2026, 08:31 UTC
On 2026-06-02, according to Xiniu Data, Omniscient Neurotechnology completed Series D financing, raising USD 27.2 million. Investors were co-lead investor OIF Ventures, co-lead investor National Reconstruction Fund Corporation, participating investor Will Vicars, participating investor Gina Rinehart AO. The company is an Australian provider of treatments for neuropsychiatric disorders.